Navigation Links
More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals

Drugs meant for treatment of Attention Deficit Hyperactivity Disorder (ADHD), Ritalin (Novartis AG) and Adderall (Shire Pharmaceuticals) would be subjected to stringent clinical trials to assess the safety and side effects // of the drug.

The decision has been taken following the reports of the U.S. advisory panel, which stated that strong warnings should be associated with marketing of such drugs. There is a possibility of sudden death, heart attacks and other complications associated with the use of the drug.

The company officials have expressed keen interest in evaluating the relationship between these drugs and cardiovascular risk, taking into consideration the physicians and affected patients. The company would also support disclosure of all information, including the warning statement.

Data from the prospective clinical trial is believed to be very crucial in deciding whether the drug should carry a black box warning. The black box warning is issue to a prescription drug that is related to dangerous side effects. When surveyed, 7 of the 8 panel members recommended a black box warning for the drug.

The drug Adderall, marketed by Shire already carries a black box warning, highlighting the possibility of sudden death or cardiovascular complications. More than 1 million ADHD prescriptions are being written for adults while children receive nearly 2 million prescriptions every year.

The ADHD drugs closely resemble amphetamines in chemical composition, known to cause hypertension, a significant predisposing factor for heart disease. With more clinical trials being planned, it would not be long before the safety of Adderall can be established.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: More Study Side Effects ADHD Drug Needed Shire Pharmaceuticals

(Date:7/9/2014)... A retrospective study conducted by researchers at Tufts University ... adults with intellectual and developmental disabilities, the likelihood of ... dental care increased. The findings, published in the July/August ... help improve interventions designed to address the oral health ... reviewed the dental records of 107 patients at one ...
(Date:7/9/2014)... , , , , , ... , , , , ... the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , , ... , , , , , ... , , , , , , University ...
(Date:7/9/2014)... of Medicine of the University of Southern California ... component of the immune system are completely resistant ... The discovery suggests that blocking this immune system ... and hyper-inflammatory diseases such as rheumatoid arthritis and ... online on June 23 in The Journal ...
(Date:7/8/2014)... The Department of Defense,s Defense Advanced Research Projects ... up to $2.5 million to develop an implantable ... stimulate neurons within the brain to help restore ... research builds on the understanding that memory is ... of the brain encode information, store it and ...
(Date:7/8/2014)... In a study published yesterday in the scientific ... Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new ... affects over 200 million people world wide. , An ... divided into small sections or ,neighborhoods., Scientists can determine ... for gene production, by looking for a marker on the ...
Breaking Medicine News(10 mins):Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3Health News:LJI develops new approach to identify genes poised to respond in asthma patients 2
... TORRANCE, Calif., April 27 According to new ... , supplements of Lactobacillus casei strain Shirota may ... fatigue syndrome (CFS). Thirty-nine patients with CFS ... Shirota or placebo for two months. Compared ...
... Services Department declares a Public Health EmergencyHARRISBURG, Pa., April ... working with federal officials to contain the impact of ... in the declaration of a national public health emergency ... to educate the public and health care providers of ...
... toxins in the products we use for lifestyle convenience, ... toxic load on our bodies contributing to chronic illnesses, ... awareness of our environmental exposures, Metametrix Clinical Laboratory ( ... release of three new testing profiles in the Toxic ...
... 100 Exhibits, Forums on Health Care and Financial Security, ... Top Musicians***LOS LOBOS TO HEADLINE ENTERTAINMENT***SAN ANTONIO, April 27 ... for people age 50+, today announced it will bring ... San Antonio on May 15-16. The two-day, cross-generational ...
... screen at 40, but yearly PSA may not be necessary, ... guidelines on prostate cancer screening suggest that annual PSA blood ... same guidelines call for a "baseline" PSA test at the ... (PSA) test to detect early signs of prostate cancer should ...
... WHAT: , Media may now register to attend ... Symposium of the Cardiovascular Research Foundation. TCT gathers ... world to present and discuss the latest developments ... medicine. Now in its 21st year, TCT brings ...
Cached Medicine News:Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 3Health News:Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health 2Health News:AARP to Host Cross-Generational 'Life Festival' in San Antonio May 15-16 2Health News:AARP to Host Cross-Generational 'Life Festival' in San Antonio May 15-16 3Health News:Experts Back Away From Annual PSA Test 2Health News:Experts Back Away From Annual PSA Test 3Health News:Media registration now open for TCT 2009 2
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ... by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), ... of Solta Medical, Inc. (NASDAQ: SLTM ) ...
(Date:1/14/2014)... Jan. 14, 2014 HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... it expects revenues for the fourth quarter of 2013 ... revenues to approximately $208 million. "Our full-year ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... OAKS, Calif., April 13, 2011 Amgen (NASDAQ: ... first quarter financial results on Wednesday, April 20, 2011 after ... be followed by a conference call with the investment community ... Amgen will be Kevin Sharer, chairman and chief executive officer, ...
... 13, 2011 Perrigo (Nasdaq: PRGO;TASE) today announced that ... TEVA ), has received final OTC approval to sell ... tablets; the generic equivalents of Sanofi-Aventis, Allegra 60 mg ... for these products, and Teva and Sanofi-Aventis have settled ...
Cached Medicine Technology:Amgen Announces Webcast of 2011 First Quarter Financial Results 2Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets 2Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: